Drug Type Biosimilar, Monoclonal antibody |
Synonyms EB1004, JHL-1255 |
Target |
Action inhibitors |
Mechanism IL-12p40 inhibitors(Interleukin-12 subunit beta inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Crohn Disease | Preclinical | Taiwan Province | 22 Mar 2022 | |
| Psoriasis | Preclinical | Taiwan Province | 22 Mar 2022 |






